Detalhe da pesquisa
1.
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.
Immunity
; 57(2): 256-270.e10, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354703
2.
Inhibitory CARs fail to protect from immediate T cell cytotoxicity.
Mol Ther
; 32(4): 982-999, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384128
3.
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.
Plant Biotechnol J
; 22(5): 1224-1237, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050338
4.
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Cancer Immunol Immunother
; 72(9): 3029-3043, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310433
5.
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Immunology
; 166(4): 507-521, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596615
6.
PD-1 blocking antibodies moonlighting as killers.
Eur J Immunol
; 51(6): 1361-1364, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954999
7.
4-1BB costimulation promotes bystander activation of human CD8 T cells.
Eur J Immunol
; 51(3): 721-733, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180337
8.
Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein.
Eur J Immunol
; 51(4): 848-863, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345332
9.
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity.
Blood
; 135(9): 597-609, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31830245
10.
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival.
Mol Ther
; 29(9): 2677-2690, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940156
11.
TIM-3 and CEACAM1 do not interact in cis and in trans.
Eur J Immunol
; 50(8): 1126-1141, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222966
12.
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Cancer Immunol Immunother
; 70(11): 3277-3289, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837851
13.
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.
J Immunol
; 200(6): 2025-2037, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431694
14.
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.
Mol Ther
; 27(2): 287-299, 2019 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573301
15.
CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro.
Cancer Immunol Immunother
; 68(8): 1359-1368, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332464
16.
The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep T cells in a quiescent state.
Eur J Immunol
; 47(1): 193-205, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718235
17.
Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d.
FASEB J
; 30(4): 1492-503, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678451
18.
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
J Immunol
; 195(2): 477-87, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041540
19.
STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cells.
FASEB J
; 29(3): 759-71, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398767
20.
TIM-3 does not act as a receptor for galectin-9.
PLoS Pathog
; 9(3): e1003253, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23555261